Neurotargeting

Neurotargeting is a private healthcare technology company developing software and data-management tools to support deep brain stimulation and other neurology workflows. The company emerged from Vanderbilt University research supported by NIH funding and focuses on improving targeting, intra-operative guidance, postoperative programming, and longitudinal management for patients receiving neuromodulation therapies. Its core platform, CranialVault, is described as a universal brain atlas and common database designed to integrate into clinical workflows and connect providers, neuroscience centers, and device manufacturers. Neurotargeting appears to operate primarily as a digital health and clinical decision-support company rather than a therapeutics developer, with commercialization centered on software for neurological and neurodegenerative disorders.